Toxoplasmosis
📧 Sign up to get email alerts when something new happens for Toxoplasmosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Role of Circulating MicroRNAs in Differentiating Psychological Disorders Among Women With Chronic Toxoplasmosis
This clinical trial by Benha University is recruiting to evaluate circulating microRNAs as biomarkers to differentiate psychological disorde…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Point of Care Testing for Presence of Current and or Previous T. Gondii Infection [NA]
Clinical trial update about a study evaluating point-of-care tests for current or past Toxoplasma gondii infection; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Isolated Positive Toxoplasma Gondii PCR in Blood
Clinical trial update noting an isolated positive Toxoplasma gondii PCR in blood for a toxoplasmosis study, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
This completed clinical trial analyzed cerebrospinal fluid in patients with cerebral toxoplasmosis to characterize CSF findings; the study a…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders
This clinical trial entry from Sohag University aims to measure the seroprevalence of Toxoplasma gondii among children with neuropsychiatric…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
Clinical trial update indicates ongoing recruitment for studying prognosis of disseminated and cerebral toxoplasmosis in ICU patients with P…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL) [NA]
TOXCELL is a completed clinical trial evaluating a cellular-immunity based approach to diagnosing Toxoplasma gondii infection. The study inc…
-
FDA approval · 2022-10-25FDA Approved: PYRIMETHAMINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for pyrimethamine from Aurobindo Pharma Limited.
-
FDA approval · 2021-08-13FDA Approved: PYRIMETHAMINE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's original application for pyrimethamine (generic) under an ANDA.
-
FDA approval · 2020-02-28FDA Approved: PYRIMETHAMINE — Original Application (DR.REDDYS LABORATORIES INC)
FDA approved a pyrimethamine product from Dr. Reddy's Laboratories under an Original Application (ANDA207127), adding a generic option for t…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects [Phase 1]
Phase I study of pyrimethamine in healthy Japanese and Caucasian subjects completed; results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Antiretroviral Drug Interaction Study in Volunteers With HIV [Phase 1]
Phase 1 trial evaluating interactions between antiretroviral drugs in volunteers with HIV; study has been completed.
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia [Phase 4]
A Phase 4 pilot trial evaluating valproate as an adjunctive treatment for Toxoplasma gondii infection in early course schizophrenia has been…
-
FDA approval · 2017-06-21FDA Approved: PYRIMETHAMINE — Supplemental Application (OAKRUM PHARMA, LLC)
FDA approved a supplemental NDA for Pyrimethamine submitted by Oakrum Pharma, LLC.
-
CLINICAL_TRIALS research · 2016-10-18Clinical Trial Update: Lyon Cohort of Maternal and Congenital Toxoplasma Infections
Clinical trial update for the Lyon cohort studying maternal and congenital toxoplasmosis; current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis [NA]
Completed clinical trial evaluating biological biomarkers for diagnosing toxoplasmosis–associated uveitis and chorioretinitis.
-
FDA approval · 2010-02-16FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic product Sulfamethoxazole and Trimethoprim as an Original Application (ANDA).